Fig. 2From: The effect of oral supplementation of Paricalcitol on C-reactive protein levels in chronic kidney disease patients: GRADE-assessed systematic review and dose-response meta-analysis of data from randomized controlled trialsForest plot detailing weighted mean difference and 95% confidence interval (Cls) for the effect of paricalcitol supplementation on C-reactive protein in CKD patients. Note Weights are from random-effects modelBack to article page